Lechner et al. demonstrated the expression of SSTR2 in 252 of 311 NPC primary R/M samples localized in the plasma membrane with enriched SSTR2 expression in EBV + and non-keratinizing subtypes, and no difference in levels between recurrent and metastatic disease [9]. Here, SSTR2 is linked to nasopharyngeal carcinoma.